Micron Biomedical

Featured

Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles

November 16, 2023

Reuters Spotlights Micron’s Progress Toward Mass Production of Its Proprietary Microarray Technology

November 16, 2023

Atlanta News First Spotlights Micron Biomedical’s “Game Changing Technology”

November 16, 2023

Micron Biomedical Spotlighted by GAVI, the Vaccine Alliance

July 6, 2023

Startups’ Patch Technologies Could Extend Reach of Vaccines

June 1, 2023

Virtually Ouch-Free? Promising Early Data On A Measles Vaccine Delivered Via Stick-On Patch

May 26, 2023

Micron Biomedical Presents at the White House Summit on the Future of COVID-19 Vaccines

July 26, 2022